These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14504774)

  • 41. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A study of the interrelationship between and comparative interrater reliability of the SAPS, SANS and PANSS.
    Norman RM; Malla AK; Cortese L; Diaz F
    Schizophr Res; 1996 Mar; 19(1):73-85. PubMed ID: 9147498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Family interactions of schizophrenic and schizoaffective patients: determinants of relatives' negativity.
    Sayers SL; Bellack AS; Mueser KT; Tierney AM; Wade JH; Morrison RL
    Psychiatry Res; 1995 Mar; 56(2):121-34. PubMed ID: 7667437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Self-awareness of cognitive functioning in schizophrenia: patients and their relatives.
    Poletti S; Anselmetti S; Riccaboni R; Bosia M; Buonocore M; Smeraldi E; Cavallaro R
    Psychiatry Res; 2012 Jul; 198(2):207-11. PubMed ID: 22406396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia.
    Berman I; Viegner B; Merson A; Allan E; Pappas D; Green AI
    Schizophr Res; 1997 May; 25(1):1-10. PubMed ID: 9176922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.
    Artaloytia JF; Arango C; Lahti A; Sanz J; Pascual A; Cubero P; Prieto D; Palomo T
    Am J Psychiatry; 2006 Mar; 163(3):488-93. PubMed ID: 16513871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationships between electrodermal activity and symptomatology in schizophrenia.
    Fuentes I; García Merita M; Miquel M; Rojo J
    Psychopathology; 1993; 26(1):47-52. PubMed ID: 8511230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.
    Keefe RS; Poe M; Walker TM; Kang JW; Harvey PD
    Am J Psychiatry; 2006 Mar; 163(3):426-32. PubMed ID: 16513863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon Family Study.
    Kendler KS; McGuire M; Gruenberg AM; Walsh D
    Am J Psychiatry; 1995 May; 152(5):755-64. PubMed ID: 7726316
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Depressive symptoms and negative symptoms during schizophrenia].
    Dollfus S; Langlois S; Assouly-Besse F; Petit M
    Encephale; 1995 Jun; 21 Spec No 3():23-7. PubMed ID: 7628337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dissociation between inattentiveness during mental status testing and social inattentiveness in the Scale for the Assessment of Negative Symptoms attention subscale.
    Atbaşoglu EC; Ozgüven HD; Olmez S
    Psychopathology; 2003; 36(5):263-8. PubMed ID: 14571056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical effects of recent cocaine use on patients with acute schizophrenia.
    Serper MR; Alpert M; Richardson NA; Dickson S; Allen MH; Werner A
    Am J Psychiatry; 1995 Oct; 152(10):1464-9. PubMed ID: 7573585
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical assessment of schizophrenic syndrome (CASS): validity evaluation of the new diagnostic tool].
    Wciórka J; Anczewska M; Bembenek A; Gołebiewska M; Hochlewicz A; Nurowska K; Schaeffer E; Skowrońska J; Stanikowska I; Tarczyńska K
    Psychiatr Pol; 2000; 34(2):203-21. PubMed ID: 10974936
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can delusions be self-assessed? Concordance between self- and observer-rated delusions in schizophrenia.
    Lincoln TM; Ziegler M; Lüllmann E; Müller MJ; Rief W
    Psychiatry Res; 2010 Jul; 178(2):249-54. PubMed ID: 20483172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Negative symptoms and emotional blunting in schizophrenic patients.
    de Leon J; Peralta V; Cuesta MJ
    J Clin Psychiatry; 1993 Mar; 54(3):103-8. PubMed ID: 8468308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia.
    Alvarez E; Ciudad A; Olivares JM; Bousoño M; Gómez JC
    J Clin Psychopharmacol; 2006 Jun; 26(3):238-49. PubMed ID: 16702888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel rating scales for schizophrenia - Targeted Inventory on Problems in Schizophrenia (TIP-Sz) and Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz).
    Suzuki T; Uchida H; Nomura K; Takeuchi H; Nakajima S; Tanabe A; Yagi G; Watanabe K; Kashima H
    Schizophr Res; 2008 Dec; 106(2-3):328-36. PubMed ID: 18804960
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Training novice raters on the Negative Symptom Assessment Scale.
    Axelrod BN; Alphs LD
    Schizophr Res; 1993 Mar; 9(1):25-8. PubMed ID: 8461268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Family interaction and the course of schizophrenic illness. Results of a multivariate prospective study.
    Stricker K; Schulze Mönking H; Buchkremer G
    Psychopathology; 1997; 30(5):282-90. PubMed ID: 9353857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.